rs243845

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004530.6(MMP2):​c.1337-583G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.389 in 151,470 control chromosomes in the GnomAD database, including 11,564 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 11564 hom., cov: 29)

Consequence

MMP2
NM_004530.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.349

Publications

19 publications found
Variant links:
Genes affected
MMP2 (HGNC:7166): (matrix metallopeptidase 2) This gene is a member of the matrix metalloproteinase (MMP) gene family, that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A, type IV collagenase, that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members, activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases, or, intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system, endometrial menstrual breakdown, regulation of vascularization, and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
MMP2 Gene-Disease associations (from GenCC):
  • multicentric osteolysis, nodulosis, and arthropathy
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • multicentric osteolysis-nodulosis-arthropathy spectrum
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.416 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004530.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MMP2
NM_004530.6
MANE Select
c.1337-583G>A
intron
N/ANP_004521.1P08253-1
MMP2
NM_001127891.3
c.1187-583G>A
intron
N/ANP_001121363.1P08253-3
MMP2
NM_001302508.1
c.1109-583G>A
intron
N/ANP_001289437.1P08253-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MMP2
ENST00000219070.9
TSL:1 MANE Select
c.1337-583G>A
intron
N/AENSP00000219070.4P08253-1
MMP2
ENST00000437642.6
TSL:1
c.1187-583G>A
intron
N/AENSP00000394237.2P08253-3
MMP2
ENST00000570308.5
TSL:1
c.1109-583G>A
intron
N/AENSP00000461421.1P08253-2

Frequencies

GnomAD3 genomes
AF:
0.390
AC:
58952
AN:
151352
Hom.:
11559
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.421
Gnomad AMI
AF:
0.290
Gnomad AMR
AF:
0.322
Gnomad ASJ
AF:
0.458
Gnomad EAS
AF:
0.285
Gnomad SAS
AF:
0.387
Gnomad FIN
AF:
0.449
Gnomad MID
AF:
0.291
Gnomad NFE
AF:
0.384
Gnomad OTH
AF:
0.355
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.389
AC:
58984
AN:
151470
Hom.:
11564
Cov.:
29
AF XY:
0.392
AC XY:
28979
AN XY:
74006
show subpopulations
African (AFR)
AF:
0.421
AC:
17331
AN:
41186
American (AMR)
AF:
0.322
AC:
4897
AN:
15216
Ashkenazi Jewish (ASJ)
AF:
0.458
AC:
1583
AN:
3460
East Asian (EAS)
AF:
0.284
AC:
1465
AN:
5156
South Asian (SAS)
AF:
0.387
AC:
1855
AN:
4790
European-Finnish (FIN)
AF:
0.449
AC:
4691
AN:
10458
Middle Eastern (MID)
AF:
0.299
AC:
88
AN:
294
European-Non Finnish (NFE)
AF:
0.384
AC:
26076
AN:
67904
Other (OTH)
AF:
0.350
AC:
735
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1780
3560
5341
7121
8901
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
564
1128
1692
2256
2820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.386
Hom.:
16607
Bravo
AF:
0.382
Asia WGS
AF:
0.318
AC:
1106
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.1
DANN
Benign
0.33
PhyloP100
-0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs243845; hg19: chr16-55526487; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.